Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Lemmens
H P
HP
Department of Surgery, University Hospital Rudolf Virchow, Free University of Berlin, Germany.
Langrehr
J M
JM
Blumhardt
G
G
Lohmann
R
R
Knoop
M
M
Verschl
J
J
Schattenfroh
N
N
Neuhaus
R
R
Hopf
U
U
Bechstein
W O
WO
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006509:Hepatitis B / Q000150:complications*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D017093:Liver Failure / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D011183:Postoperative Complications / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000276:immunology; D012008:Recurrence; D012086:Reoperation / Q000706:statistics & numerical data; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D006514:Hepatitis B Surface Antigens; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D011239:Prednisolone; C079843:inolimomab; D001379:Azathioprine; D016559:Tacrolimus